oncolex logo
Utskriftsdato 23.10.2019

Differential diagnoses of multiple myeloma

Differential diagnostics are intended to differentiate multiple myeloma from other malignant diseases with bone marrow involvement, chronic inflammation conditions, and lymphoproliferative diseases.

MGUS

A M-component with < 30 g/l and < 10 % plasma cells in bone marrow biopsy which is not accompanied by symptoms, biomarkers or signs of multiple myloma or other B-lymphoproliferative disease is called MGUS (monoclonal gammopathy of undetermined significance).

The differentiation between MGUS and smouldering multiple myloma is based on the size of the M-component and/or amount of plasma cells in the bone marrow. However, there is no indication for treatment until (symptomatic) multiple myeloma is present.

MGUS is relatively common (up to 3% in people over 50). Thus, most persons having M-protein in their serum have MGUS and not cancer of the bone marrow.

Other conditions where the M-protein may be present are:

  • AL-amyloidosis
  • Solitary plasmacytoma
  • B-cell non-Hodgkin lymphoma (including Waldenström macroglobulinemia)
  • Chronic lymphatic leukemia
  • Autoimmune disease such as SLE